Short-term day-time periodic breathing is not a risk factor for life-threatening arrhythmias in patients with heart failure

2008 ◽  
Vol 7 ◽  
pp. 102-102
Author(s):  
M LAROVERE ◽  
G PINNA ◽  
R MAESTRI ◽  
F OLMETTI ◽  
E ROBBI ◽  
...  
Heart ◽  
2001 ◽  
Vol 85 (5) ◽  
pp. 514-520
Author(s):  
W Y Kim ◽  
P Søgaard ◽  
P T Mortensen ◽  
H Kjærulf Jensen ◽  
A Kirstein Pedersen ◽  
...  

OBJECTIVESTo quantify the short term haemodynamic effects of biventricular pacing in patients with heart failure and left bundle branch block by using three dimensional echocardiography.DESIGNThree dimensional echocardiography was performed in 15 consecutive heart failure patients (New York Heart Association functional class III or IV) with an implanted biventricular pacing system. Six minute walk tests were performed to investigate the effect of biventricular pacing on exercise capacity. Data were acquired at sinus rhythm and after short term (2–7 days) biventricular pacing.RESULTSCompared with baseline values, biventricular pacing significantly reduced left ventricular end diastolic volume (EDV) by mean (SD) 4.0 (5.1)% (p < 0.01) and end systolic volume (ESV) by 5.6 (6.4)% (p < 0.02). Mitral regurgitant fraction was significantly reduced by 11 (12.1)% (p < 0.003) and forward stroke volume (FSV) increased by 13.9 (18.6)% (p < 0.02). Exercise capacity was significantly improved with biventricular pacing by 48.4 (43.3)% (p < 0.00001). Regression analyses showed that the percentage increase in FSV independently predicted percentage improvement in walking distance (r2 = 0.73, p < 0.0002). Both basal QRS duration and QRS narrowing predicted pacing efficacy, showing a significant correlation with %ΔEDV, %ΔESV, and %ΔFSV.CONCLUSIONSIn five of 15 consecutive patients with heart failure and left bundle branch block, biventricular pacing induced a more than 15% increase in FSV, which predicted a more than 25% increase in walking distance and was accompanied by an immediate reduction in left ventricular chamber size and mitral regurgitation.


Heart ◽  
2016 ◽  
Vol 102 (22) ◽  
pp. 1820-1825 ◽  
Author(s):  
Romano Endrighi ◽  
Andrew J Waters ◽  
Stephen S Gottlieb ◽  
Kristie M Harris ◽  
Andrew J Wawrzyniak ◽  
...  

2009 ◽  
Vol 50 (5) ◽  
pp. 493-499 ◽  
Author(s):  
Chiara Rafanelli ◽  
Yuri Milaneschi ◽  
Renzo Roncuzzi

2011 ◽  
Vol 17 (9) ◽  
pp. S167
Author(s):  
Ryuichiro Fukushima ◽  
Eiji Taguchi ◽  
Tomohiro Sakamoto ◽  
Kazuhiro Nishigami ◽  
Toshihiro Honda ◽  
...  

2020 ◽  
Vol 4 (53) ◽  
pp. 19-22
Author(s):  
Przemysław Mitkowski

Up-date of ESC Guidelines on management of patients with heart failure was published last year. Beside topics related to pharmacological treatment one can find also chapters dedicated to non-pharmacological management. In the field of ICD therapy Authors propose one may consider not to implant the device in patients over 70 years old, especially when they suffer from advanced heart failure and life-threatening comorbidities. It is in contra with meta-analysis presented after results of DANISH trial has been published, which underlined benefits of ICD treatment in such patients. Moreover in patients randomized to treatment without ICD almost 60% received CRTP. It is also important that 24 patients randomized to no-ICD group finally received ICD because of appearance of life-threatening ventricular arrhythmia. In such situation additional on-treatment analysis would be beneficial. One can get an impression that pulmonary vein ablation in patients with heart failure and atrial fibrillation achieve enough high level of recommendation despite favourable results of CASTLE-AF and on-treatment analysis of CABANA trials. Analysis of data according to received treatment seemed to be beneficial especially when the percentage of crossover is significant. Functional mitral regurgitation should be managed after meaningful analysis of each case and referral to MitraClip implantation should be based on the protocol of COAPT trial which proves benefits of a such device implantation.


2017 ◽  
Vol 20 (5) ◽  
pp. 934-936 ◽  
Author(s):  
Maria Teresa La Rovere ◽  
Roberto Maestri ◽  
Elena Robbi ◽  
Angelo Caporotondi ◽  
Giampaolo Guazzotti ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document